HomeCompareIXOG vs MRK

IXOG vs MRK: Dividend Comparison 2026

IXOG yields 285714.29% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IXOG wins by $1.734986541242196e+31M in total portfolio value
10 years
IXOG
IXOG
● Live price
285714.29%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.734986541242196e+31M
Annual income
$17,337,928,197,276,910,000,000,000,000,000,000,000.00
Full IXOG calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — IXOG vs MRK

📍 IXOG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIXOGMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IXOG + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IXOG pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IXOG
Annual income on $10K today (after 15% tax)
$24,285,714.29/yr
After 10yr DRIP, annual income (after tax)
$14,737,238,967,685,373,000,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, IXOG beats the other by $14,737,238,967,685,373,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IXOG + MRK for your $10,000?

IXOG: 50%MRK: 50%
100% MRK50/50100% IXOG
Portfolio after 10yr
$8.67493270621098e+30M
Annual income
$8,668,964,098,638,455,000,000,000,000,000,000,000.00/yr
Blended yield
99.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

IXOG
No analyst data
Altman Z
-0.7
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IXOG buys
0
MRK buys
0
No recent congressional trades found for IXOG or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIXOGMRK
Forward yield285714.29%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1.734986541242196e+31M$56.8K
Annual income after 10y$17,337,928,197,276,910,000,000,000,000,000,000,000.00$9,798.13
Total dividends collected$1.734908400352195e+31M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: IXOG vs MRK ($10,000, DRIP)

YearIXOG PortfolioIXOG Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$28,582,129$28,571,428.57$11,206$366.19+$28.57MIXOG
2$76,351,353,429$76,320,770,551.21$12,650$502.35+$76351.34MIXOG
3$190,619,493,207,524$190,537,797,259,355.30$14,407$694.19+$190619493.19MIXOG
4$444,781,927,427,195,200$444,577,964,569,463,100.00$16,585$967.82+$444781927427.18MIXOG
5$969,967,353,346,567,200,000$969,491,436,684,220,000,000.00$19,342$1,363.89+$969967353346567.13MIXOG
6$1,976,961,629,315,093,000,000,000$1,975,923,764,247,012,300,000,000.00$22,913$1,947.19+$1976961629315092992.00MIXOG
7$3,765,923,944,594,039,000,000,000,000$3,763,808,595,650,671,000,000,000,000.00$27,662$2,823.89+$3.765923944594039e+21MIXOG
8$6,704,681,437,057,684,000,000,000,000,000$6,700,651,898,436,968,000,000,000,000,000.00$34,159$4,173.35+$6.704681437057683e+24MIXOG
9$11,156,275,836,497,016,000,000,000,000,000,000$11,149,101,827,359,364,000,000,000,000,000,000.00$43,337$6,308.80+$1.1156275836497015e+28MIXOG
10$17,349,865,412,421,960,000,000,000,000,000,000,000$17,337,928,197,276,910,000,000,000,000,000,000,000.00$56,776$9,798.13+$1.734986541242196e+31MIXOG

IXOG vs MRK: Complete Analysis 2026

IXOGStock

Index Oil and Gas Inc., through its subsidiaries, engages in the acquisition, exploration, appraisal, development, production, and sale of oil and gas properties, primarily in Kansas, Louisiana, and Texas. As of March 31, 2009, the company's estimated total proved oil and gas reserves were approximately 87.703 thousands of barrels of oil equivalent, including 20.967 thousand barrels of oil and 400.414 million cubic feet of natural gas. Index Oil and Gas Inc. was founded in 2003 and is based in Houston, Texas. On November 17, 2010, Index Oil and Gas, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Southern District of Texas. Index Oil & Gas, Inc. is in liquidation.

Full IXOG Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this IXOG vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IXOG vs SCHDIXOG vs JEPIIXOG vs OIXOG vs KOIXOG vs MAINIXOG vs JNJIXOG vs ABBVIXOG vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.